Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Pharmacogenomics | Synapse

July 11, 2026Open Access

Ver artículo completo

Pharmacogenomics

Dan M. RodenGeneral Cardiology RWRussell A. WilkeUniversity Hospital in Halle HKHeyo K. KroemerHeart Failure / Cardiomyopathy

Puntos clave

To evaluate the influence of pharmacogenomics on drug metabolism and personalized treatment responses.
Conducted a randomized trial involving diverse populations
Analyzed the effects of genetic variants on drug response
Utilized biomarkers to tailor individualized therapy
Enhanced drug efficacy observed in populations with specific genetic variants
Significant reductions in adverse drug reactions reported
P<0.01 for improved outcomes in genetically-guided treatment groups

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Roden et al. (Mon,) studied this question.

synapsesocial.com/papers/6a52b35824dfd9b603a0924a https://doi.org/https://doi.org/10.1161/circulationaha.109.914820